Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115040448 | 11504044 | 8 | F | 2011 | 20160909 | 20150914 | 20160914 | EXP | PHHY2015BR104865 | NOVARTIS | 75.06 | YR | F | Y | 49.00000 | KG | 20160914 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115040448 | 11504044 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 1 DF, QMO | 21008 | 1 | DF | SUSPENSION | /month | ||||||
| 115040448 | 11504044 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 4 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 7 | C | ASA | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 115040448 | 11504044 | 8 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 115040448 | 11504044 | 9 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115040448 | 11504044 | 1 | Neuroendocrine tumour |
| 115040448 | 11504044 | 2 | Diabetes mellitus |
| 115040448 | 11504044 | 3 | Hypertension |
| 115040448 | 11504044 | 4 | Hypertension |
| 115040448 | 11504044 | 5 | Hypertension |
| 115040448 | 11504044 | 6 | Gastritis erosive |
| 115040448 | 11504044 | 7 | Cardiac disorder |
| 115040448 | 11504044 | 8 | Hypertension |
| 115040448 | 11504044 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115040448 | 11504044 | HO |
| 115040448 | 11504044 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115040448 | 11504044 | Abdominal adhesions | |
| 115040448 | 11504044 | Abdominal discomfort | |
| 115040448 | 11504044 | Abdominal distension | |
| 115040448 | 11504044 | Abdominal pain | |
| 115040448 | 11504044 | Blood cholesterol increased | |
| 115040448 | 11504044 | Blood creatinine increased | |
| 115040448 | 11504044 | Burning sensation | |
| 115040448 | 11504044 | Concomitant disease aggravated | |
| 115040448 | 11504044 | Confusional state | |
| 115040448 | 11504044 | Diarrhoea | |
| 115040448 | 11504044 | Disorientation | |
| 115040448 | 11504044 | Disturbance in attention | |
| 115040448 | 11504044 | Drug ineffective | |
| 115040448 | 11504044 | Dysgeusia | |
| 115040448 | 11504044 | Erythema | |
| 115040448 | 11504044 | Hepatic function abnormal | |
| 115040448 | 11504044 | Hypersensitivity | |
| 115040448 | 11504044 | Hypoaesthesia | |
| 115040448 | 11504044 | Joint swelling | |
| 115040448 | 11504044 | Laziness | |
| 115040448 | 11504044 | Malaise | |
| 115040448 | 11504044 | Malignant neoplasm progression | |
| 115040448 | 11504044 | Nausea | |
| 115040448 | 11504044 | Neoplasm progression | |
| 115040448 | 11504044 | Pain | |
| 115040448 | 11504044 | Peripheral swelling | |
| 115040448 | 11504044 | Pruritus | |
| 115040448 | 11504044 | Rash | |
| 115040448 | 11504044 | Rash papular | |
| 115040448 | 11504044 | Recurrent cancer | |
| 115040448 | 11504044 | Scratch | |
| 115040448 | 11504044 | Sleep disorder | |
| 115040448 | 11504044 | Swelling | |
| 115040448 | 11504044 | Tumour pain | |
| 115040448 | 11504044 | Vomiting | |
| 115040448 | 11504044 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115040448 | 11504044 | 1 | 2010 | 0 | ||
| 115040448 | 11504044 | 2 | 2010 | 0 | ||
| 115040448 | 11504044 | 7 | 2010 | 0 |